AI Biomed

Ai Biomed is the startup founded in 2018 for development of the medical equipment on the basis of AI. Its main development represents the instrument of determination of parathyroid glands PTeye in real time which can be used during the difficult surgical procedures on a neck, for example, at a tireoidektomiya and a paratireoidektomiya.

History

2020: Medtronic purchased AI Biomed

At the end of October, 2020 Medtronic announced Ai Biomed acquisition. The cost of the transaction of the company did not begin to be disclosed.

Tissue of a parathyroid gland can be difficult to distinguish visually from surrounding fabric during transaction. To save healthy fabrics during transaction, surgeons use the devices helping to visualize parathyroid glands. According to the developer, PTeye represents unique technology which provides visual identification of fabric without contrasting. In particular, PTeye uses the laser probe for obtaining the fluorescent answer from tissue of a parathyroid gland, at the same time need for contrast substance disappears by itself.

Medtronic purchased the developer of the equipment for recognition of a parathyroid gland without contrast of AI Biomed

Protection of critical structures during transaction turned into a specialized system which transfers important information to the surgeon in real time, - professor of otolaryngology of the Harvard medical school, doctor Gregory Randolph noted in the press release. - Our eyes and hands have restrictions, but the PTeye system allows surgeons to optimize the course of the procedure and to improve results of treatment.

This acquisition became the seventh in a series of the additional bargains concluded by Medtronic during 2020. The company expects that revenue and profit on this acquisition will be insignificant in the first year, but will begin to grow further. The staff of Ai Biomed from Santa Barbara, the State of California, also to join LOR-business of Medtronic within acquisition.^[1]

Notes